Urinary tract infections in men - Symptoms, Causes, Images, and Treatment Options

Diseases

Highlights & Basics

Key Highlights

Urinary tract infection (UTI) in men rarely occurs before 50 years of age.
Often associated with abnormal structure or function of the urinary tract (complicated UTI).
Catheter-associated UTI is the most common cause of nosocomial infection.
Imaging of the urinary tract is recommended for men with persistent hematuria, voiding dysfunction without a clearly identifiable cause such as benign prostatic hyperplasia (BPH), failure of initial therapy, or signs of upper tract infection.
Treatment with a fluoroquinolone antibiotic is generally appropriate in men as they are likely to have a UTI classified as complicated. Asymptomatic bacteriuria does not require treatment except before urologic procedures.

Quick Reference

History & Exam
- Key Factors
- Other Factors
More information...
Diagnostics Tests
More information...
Treatment Options
More information...

Definition

Epidemiology

Etiology

Pathophysiology

Citations

Key Articles

Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019 May 2;68(10):e83-e110.[Abstract][Full Text]
European Association of Urology. Guidelines on urological infections. Mar 2022 [internet publication].[Full Text]
European Association of Urology. Guidelines on urological infections. Apr 2024 [internet publication].[Full Text]

Referenced Articles

1. Ronald AR, Harding GK. Complicated urinary tract infections. Infect Dis Clin North Am. 1997 Sep;11(3):583-92.[Abstract]
2. Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract. 2002 Sep;52(482):752-61.[Abstract][Full Text]
3. Ulleryd P, Zackrisson B, Aus G, et al. Selective urological evaluation in men with febrile urinary tract infection. BJU Int. 2001 Jul;88(1):15-20.[Abstract]
4. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019 May 2;68(10):e83-e110.[Abstract][Full Text]
5. Schaeffer AJ. Infections of the urinary tract. In: Walsh PC, ed. Campbells' urology, 8th ed. Philadelphia, PA: Saunders; 2002.
6. Roberts RG, Hartlaub PP. Evaluation of dysuria in men. Am Fam Physician. 1999 Sep 1;60(3):865-72.[Abstract]
7. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002 Jul 8;113(suppl 1A):5-13S.[Abstract]
8. Saint S, Kowalski CP, Kaufman SR, et al. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis. 2008 Jan 15;46(2):243-50.[Abstract][Full Text]
9. Griebling TL. Urologic diseases in america project: trends in resource use for urinary tract infections in men. J Urol. 2005 Apr;173(4):1288-94.[Abstract][Full Text]
10. Schaeffer AJ, Nicolle LE. CLINICAL PRACTICE. Urinary Tract Infections in Older Men. N Engl J Med. 2016 Feb 11;374(6):562-71.[Abstract][Full Text]
11. Shortliffe LM, McCue JD. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med. 2002 Jul 8;113(suppl 1A):55S-66S.[Abstract]
12. Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in healthy university men. J Urol. 1993 May;149(5):1046-8.[Abstract]
13. Lipsky BA. Prostatitis and urinary tract infection in men: what's new; what's true? Am J Med. 1999 Mar;106(3):327-34.[Abstract]
14. Hummers-Pradier E, Ohse AM, Koch M, et al. Urinary tract infection in men. Int J Clin Pharm. 2004 Jul;42(7):360-6.[Abstract]
15. Cornia PB, Takahashi TA, Lipsky BA. The microbiology of bacteriuria in men: a 5-year study at a Veterans' Affairs hospital. Diagn Microbiol Infect Dis. 2006 Sep;56(1):25-30.[Abstract]
16. Schwartz DS, Barone JE. Correlation of urinalysis and dipstick results with catheter-associated urinary tract infections in surgical ICU patients. Intensive Care Med. 2006 Nov;32(11):1797-801.[Abstract]
17. Tomera KM, Burdmann EA, Pamo Reyna OG, et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother. 2002 Sep;46(9):2895-900.[Abstract][Full Text]
18. Abraham SN, Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015 Oct;15(10):655-63.[Abstract][Full Text]
19. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993 Oct 28;329(18):1328-34.[Abstract]
20. Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol. 1995 Jan 15;141(2):145-57.[Abstract]
21. Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35(1):34-9.[Abstract]
22. Ferri C, Marchetti F, Nickel JC, et al. Prevalence and clinical management of complicated urinary tract infections in Italy: a prospective multicenter epidemiological study in urological outpatients. J Chemother. 2005 Dec;17(6):601-6.[Abstract]
23. Coull N, Mastoroudes H, Popert R, et al. Redefining urological history taking - anal intercourse as the cause of unexplained symptoms in heterosexuals. Ann R Coll Surg Engl. 2008 Jul;90(5):403-5.[Abstract][Full Text]
24. Barnes RC, Roddy RF, Daifuku R, et al. Urinary-tract infection in sexually active homosexual men. Lancet. 1986 Jan 25;1(8474):171-3.[Abstract]
25. Lipsky BA, Schaberg DR. Managing urinary tract infections in men. Hosp Prac. 2000 Jan 15;35(1):53-9.[Abstract]
26. Andrews SJ, Brooks PT, Hanbury DC, et al. Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study. BMJ. 2002 Feb 23;324(7335):454-6.[Abstract][Full Text]
27. Huang W, Wann S, Lin S, et al. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters. Infect Control Hosp Epidemiol. 2004 Nov;25(11):974-8.[Abstract]
28. European Association of Urology. Guidelines on urological infections. Mar 2022 [internet publication].[Full Text]
29. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1;50(5):625-63.[Abstract][Full Text]
30. Russell DB, Roth NJ. Urinary tract infections in men in a primary care population. Aust Fam Physician. 2001 Feb;30(2):177-9.[Abstract]
31. Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child. 2005 Aug;90(8):853-8.[Abstract][Full Text]
32. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med. 2006 Jan 17;144(2):116-26.[Abstract][Full Text]
33. Lam TB, Omar M, Fisher E, et al. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014 Sep 23;(9):CD004013.[Abstract][Full Text]
34. Drekonja DM, Kuskowski MA, Wilt TJ, et al. Antimicrobial urinary catheters: a systematic review. Exp Rev Med Devices. 2008 Jul;5(4):495-506.[Abstract]
35. Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008 Feb;31(suppl 1):S68-78.[Abstract]
36. Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med. 2007 Sep 4;147(5):285-93.[Abstract]
37. Pickard R, Lam T, MacLennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012 Dec 1;380(9857):1927-35.[Abstract]
38. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD001321.[Abstract][Full Text]
39. Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res. 2007 Jun;51(6):738-45.[Abstract]
40. Lee BS, Bhuta T, Simpson JM, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD003265.[Abstract][Full Text]
41. Cruz F, Dambros M, Naber KG, et al. Recurrent urinary tract infections: Uro-Vaxom, a new alternative. Eur Urol Suppl. 2009;8:762-8.
42. Naber KG, Cho YH, Matsumoto T, et al. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009 Feb;33(2):111-9.[Abstract]
43. Devillé WL, Yzermans JC, van Duijn NP, et al. The urine dipstick test useful to rule out infections: a meta-analysis of the accuracy. BMC Urol. 2004 Jun 2;4:4.[Abstract][Full Text]
44. AMDA - The Society for Post-Acute and Long-Term Care Medicine. Fifteen things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022 [internet publication].[Full Text]
45. European Association of Urology. Guidelines on urological infections. Apr 2024 [internet publication].[Full Text]
46. Lipsky BA, Ireton RC, Fihn SD, et al. Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis. 1987 May;155(5):847-54.[Abstract]
47. American Society for Microbiology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022 [internet publication].[Full Text]
48. Jiyong J, Tiancha H, Wei C, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med. 2009 Apr;35(4):587-95.[Abstract]
49. Masson P, Matheson S, Webster AC, et al. Meta-analyses in prevention and treatment of urinary tract infections. Infect Dis Clin North Am. 2009 Jun;23(2):355-85.[Abstract]
50. Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010 Jun 15;50(12):1641-52.[Abstract][Full Text]
51. Whelan P. Manage urinary tract infections. Practitioner. 2006 Sep;250(1686):38,41,43.[Abstract]
52. Henderson JT, Webber EM, Bean SI. Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 Sep 24;322(12):1195-1205.[Abstract][Full Text]
53. Lightner DJ, Wymer K, Sanchez J, et al. Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis. J Urol. 2020 Feb;203(2):351-356.[Abstract][Full Text]
54. Public Health England. Urinary tract infection: diagnostic tools for primary care. Oct 2020 [internet publication].[Full Text]
55. Gupta K. Addressing antibiotic resistance. Am J Med. 2002 Jul 8;11(suppl 1A):29S-34S.[Abstract]
56. Le TP, Miller LG. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis. 2001 Sep 1;33(5):615-21.[Abstract][Full Text]
57. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med. 2002 Jul 8;113(suppl 1A):1S-4S.[Abstract]
58. Smith JW, Jones SR, Reed WP, et al. Recurrent urinary tract infections in men. Ann Intern Med. 1979 Oct;91(4):544-8.[Abstract]
59. Nicolle LE, Louie TJ, Dubois J, et al. Treatment of complicated urinary tract infection with lomefloxacin compared with that with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1994 Jun;38(6):1368-73.[Abstract][Full Text]
60. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 2018 [internet publication].[Full Text]
61. US Food & Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Jul 2018 [internet publication].[Full Text]
62. US Food & Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].[Full Text]
63. Mombelli G, Pezzoli R, Pinoja-Lutz G, et al. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections. Arch Intern Med. 1999 Jan 11;159(1):53-8.[Abstract][Full Text]
64. Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003237.[Abstract][Full Text]
65. Dhillon S. Meropenem/vaborbactam: a review in complicated urinary tract infections. Drugs. 2018 Aug;78(12):1259-70.[Abstract][Full Text]
66. Wagenlehner FME, Cloutier DJ, Komirenko AS, et al. Once-daily plazomicin for complicated urinary tract infections. N Engl J Med. 2019 Feb 21;380(8):729-40.[Abstract][Full Text]
67. Bassetti M, Echols R, Matsunaga Y, et al. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2020 Oct 12 [Epub ahead of print].[Abstract][Full Text]
68. Lee YR, Yeo S. Cefiderocol, a new siderophore cephalosporin for the treatment of complicated urinary tract infections caused by multidrug-resistant pathogens: preclinical and clinical pharmacokinetics, pharmacodynamics, efficacy and safety. Clin Drug Investig. 2020 Oct;40(10):901-13.[Abstract][Full Text]
69. Sims M, Mariyanovski V, McLeroth P, et al. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections. J Antimicrob Chemother. 2017 Sep 1;72(9):2616-26.[Abstract][Full Text]
70. van Nieuwkoop C, van der Starre WE, Stalenhoef JE, et al. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. BMC Med. 2017 Apr 3;15(1):70.[Abstract][Full Text]
71. Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008 Jan;71(1):17-22.[Abstract]
72. Aziminia N, Hadjipavlou M, Philippou Y, et al. Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 2019 May;123(5):753-768.[Abstract][Full Text]
73. National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. Oct 2018 [internet publication].[Full Text]
74. National Institute for Health and Care Excellence. Urinary tract infection (catheter-associated): antimicrobial prescribing. Nov 2018 [internet publication].[Full Text]
75. National Institute for Health and Care Excellence. Pyelonephritis (acute): antimicrobial prescribing. Oct 2018 [internet publication].[Full Text]
76. National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing. Oct 2018 [internet publication].[Full Text]
77. Nicolle LE, Bjornson J, Harding GK, et al. Bacteriuria in elderly institutionalized men. N Engl J Med. 1983 Dec 8;309(23):1420-5.[Abstract]
78. Leone M, Albanese J, Garnier F, et al. Risk factors for nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med. 2003 Jul;29(7):1077-80.[Abstract]
79. Smithson A, Ramos J, Niño E, et al. Characteristics of febrile urinary tract infections in older male adults. BMC Geriatr. 2019 Nov 29;19(1):334.[Abstract][Full Text]
80. Hamasuna R, Takahashi S, Yamamoto S, et al. Guideline for the prevention of health care-associated infection in urological practice in Japan. Int J Urol. 2011 Jul;18(7):495-502.[Abstract][Full Text]